Kilo kayb genellikle itahn azalmas, porsiyonlarn klmesi, tokluk sresinin uzamas ve gnlk kalori almnn dmesiyle dolayl olarak gerekleir
Keywords: pediatric obesity, GLP-1 receptor agonists, semaglutide, adolescent weight management, pharmacotherapy, long-term safety, health equity, obesity treatment Introduction The global pediatric obesity epidemic represents one of the most pressing public health challenges of the 21st century
Establishing clear boundaries around high-risk foods and situations identified during treatment helps maintain dietary structure
In a maintenance trial, nausea fell from 47% during escalation to 14% after the 2.4 mg dose was held. Are symptoms not listed on the semaglutide label still reported
10.1182/blood-2016-05-715870 76 SmithA.McCullohR